Skip to main content

Unlocking Psilocybin’s Potential: A New Frontier in Anorexia Treatment

In a groundbreaking pilot study, scientists are paving a hopeful path for the utilization of psilocybin, a compound found in “magic mushrooms“, as a promising treatment avenue for adults grappling with anorexia nervosa, a severe condition currently lacking approved pharmacological interventions. In a pioneering trial led by Dr. Stephanie Knatz Peck and her team at the University of California San Diego, a single 25-mg dose of synthetic psilocybin coupled with psychological support emerged as a well-tolerated and potentially transformative intervention for women with anorexia.

Notably, the participants – all of whom met the DSM-5 criteria for anorexia nervosa or were in partial remission – experienced a substantial decrease in weight and shape concerns, with effects sustained up to three months post-treatment. While variations in the impact were observed, an overwhelming majority recounted a heightened sense of optimism and a positive shift in their personal identity and life perspective following the treatment, with many even ranking the experience among the most meaningful events of their lives.

Sponsored by Compass Pathways, which also furnished the synthetic psilocybin formulation COMP360, the study signifies a thrilling stride in the burgeoning field of psychedelic therapy, which is concurrently being explored for its efficacy in treating conditions like treatment-resistant depression and PTSD.

Despite the small sample size and absence of a control group marking the study’s limitations, the promising results have propelled the launch of a more extensive Phase II trial. As researchers stand on the cusp of potentially revolutionizing anorexia treatment, the community holds its breath for a therapeutic approach that might finally bring enduring relief to those afflicted by this grave disorder, underscoring the vital need for innovative strategies to enhance treatment engagement and outcomes in the battle against anorexia.

The promising results emerging from the study of psilocybin therapy for anorexia nervosa point to a burgeoning paradigm shift in psychiatric treatment methodologies. The study, helmed by Dr. Stephanie Knatz Peck, parallels a wider movement in psychiatric research, which is progressively exploring the therapeutic potentials of substances previously classified strictly within a recreational or illicit framework.

Similarly, oral ketamine, another compound with a history of recreational use, has been ushered into the limelight as a potential game-changer in the treatment of various psychiatric disorders, including anorexia.

As we stand on the threshold of what seems to be a new era in psychiatric treatment, it becomes increasingly evident that the potential applications of substances like psilocybin and ketamine are far-reaching. Both compounds have demonstrated a capacity to foster profound shifts in perception, identity, and overall quality of life in individuals grappling with complex psychiatric disorders, including anorexia nervosa.

Moreover, the combination of these substances with psychological support seems to amplify their therapeutic potential, nurturing deeper levels of healing and insight. This hints at the possibility of integrated treatment protocols in the near future that could revolutionize the management and potential recovery pathways for individuals with anorexia and other psychiatric conditions.

With continued research and a commitment to exploring innovative treatment avenues, we might be witnessing the dawn of a new epoch in psychiatry. One where previously stigmatized substances are re-evaluated and potentially re-purposed to craft more nuanced, holistic, and profoundly transformative therapeutic experiences, possibly opening doors to recovery avenues hitherto untraveled, and shedding new light on the complex landscape of human psychology and wellbeing.

Call us today to learn more about your treatment options for anorexia nervosa in Los Angeles. Our experienced therapists will walk you through our ketamine-assisted psychotherapy protocols to build you a personalized treatment plan. Get started on your journey to mental wellbeing today.

Link to the full article

California Moves Closer to Legalizing Certain Psychedelic Drugs with Senate Bill 58

California’s State Assembly has greenlighted Senate Bill 58, a pioneering legislation aiming to legalize the personal possession and use of select natural psychedelic substances for adults aged 21 and above. The bill, championed by San Francisco Democrat Scott Wiener, has undergone revisions in the Assembly following its approval by the Senate earlier this year.

The current version of the bill permits the possession and cultivation of restricted quantities of psilocybin, psilocin, mescaline, and dimethyltryptamine (DMT) – compounds found naturally in certain plants and fungi known for their potential therapeutic benefits in treating mental health disorders like depression and PTSD. Advocates emphasize the significant promise these substances hold in alleviating the nation’s mounting mental health crisis, noting their non-addictive nature and capacity for healing.

The legislation mandates the establishment of a working group under the California Health and Human Services Agency to study the implications of psychedelic use, focusing on safety, efficacy in treating various mental health conditions, and the development of a regulated framework for therapeutic applications. This step signals a progressive move towards recognizing the potential benefits of psychedelics in treating an array of serious mental health conditions, as substantiated by numerous studies and clinical trials.

Senate Bill 58 has garnered substantial support, particularly among mental health clinicians and those struggling with mental health issues who have tried conventional therapies with no success, who see this as a hopeful avenue to access these promising plant-based medicines without criminal repercussions. The bill, which has faced amendments including the establishment of possession limits and the exclusion of synthetic psychedelics like LSD and MDMA, is slated to return to the Senate for approval of the changes before moving to Governor Gavin Newsom’s desk for final endorsement.

The potential passage of this revolutionary bill could signify a watershed moment for psychedelic-assisted therapy clinics in California. As the bill directs the establishment of a structured group to conduct comprehensive studies and propose regulatory frameworks, it could pave the way for clinics to operate within a clearer, legally sanctioned environment. Furthermore, the clinics might witness a surge in demand as individuals seek individual and group therapy options that incorporate these newly legalized substances.

By potentially fostering collaborations with biopharmaceutical entities researching psychedelic compounds, these clinics could become frontiers of innovation, offering advanced, evidence-based treatment modalities for individuals grappling with persistent mental health conditions, thus marking a revolutionary shift in the landscape of mental health care in the state.

The Psychedelica Collective in Beverly Hills is at the forefront of this revolution, offering individual and group ketamine-assisted psychotherapy for those struggling with depression, anxiety, PTSD, and a wide range of other mental health concerns. Call us today for a no-obligation consultation on whether ketamine-assisted therapy is right for you.

Link to full article on Forbes.

Toad Venom: A Promising, Time-Efficient Alternative to Psilocybin for Depression Treatment

Research into the therapeutic potential of psychedelics is gaining momentum as scientists seek to understand the mechanisms behind their effects on the treatment of mental disorders such as depression, anxiety and PTSD. Psychedelics may provide lasting symptom relief through neurological changes, which can lead to transformative insights and new perspectives on one’s self and the universe.

Johns Hopkins researchers are exploring the potential of 5-MeO-DMT, a psychoactive substance found in some toad venom, as a more time-efficient alternative to psilocybin for treating depression and anxiety. While psilocybin therapy has shown promise, its lengthy 4-6 hour sessions may make it difficult for health insurance companies to cover treatment costs if the FDA indicates this substance safe for therapeutic use.

DMT, which has a much shorter duration of action, could offer similar therapeutic benefits in less time. Preliminary studies indicate that it may help combat depression and anxiety effectively, with users experiencing a powerful, mystical experience that alters their perspective on life. Further research is needed to build a case for clinical studies and to better understand how these substances provide relief for individuals suffering from mental health issues.

Despite challenges in obtaining funding for studying these substances not yet FDA indicated for therapeutic use, dedicated researchers like Davis are committed to exploring all avenues to provide better treatment and outcomes for individuals suffering from debilitating mental health issues.

Link to original article by Brennen Jensen.

For more information on ketamine assisted psychotherapy in Los Angeles, contact the Psychedelica Collective by calling (888) 850-0028 or filling out the form here.

Psilocybin Shows Promise in Treating Body Dysmorphic Disorder, but Not Social Anxiety

A recent study presented at the 2023 Anxiety and Depression Association of America (ADAA) Conference reported that psilocybin, a psychedelic substance found in some species of mushrooms, may improve symptoms of body dysmorphic disorder (BDD), but not social anxiety. BDD is a mental health condition where a person obsesses over perceived flaws in their appearance, often leading to social anxiety.

The study recruited 12 patients who received a single dose of psilocybin paired with psychological support. The researchers measured the patients’ experiences and symptoms over a 12-week period using various questionnaires and scales. Results showed that while BDD symptoms improved significantly during the treatment period, social anxiety symptoms did not.

The study also found that patients who had fewer negative aspects of the psychedelic experience and higher positive aspects showed greater improvement in BDD symptoms. However, the effects seemed to diminish over time.

Link to original article by Abdullah Hashmi, MD

As the field of psychedelic therapy continues to expand, researchers are increasingly exploring the potential of substances like psilocybin to treat various mental health conditions. Early studies like this open the door for further investigations into how psilocybin and other psychedelics may be utilized in personalized treatment plans. In the future, a better understanding of the mechanisms behind the effects of these substances could lead to more targeted and effective therapies, ultimately transforming the way we approach mental health treatment.

While psilocybin is currently not FDA approved for therapeutic use, other psychedelics like ketamine are available to those looking to seek relief from persistent symptoms of depression, anxiety, or PTSD. For those seeking ketamine for mental health, it is highly recommended to find clinics that offer in person preparation, supervised sessions, and integration session to get the full benefit. Furthermore, new telehealth laws may prohibit the prescription of these drugs in virtual care settings in the near future.

For more information about ketamine assisted therapy and if you might be a good fit for treatment, contact the Psychedelica Collective in Los Angeles today.

Unveiling the Potential of Psychedelic-Assisted Therapy: A Deep Dive into Treatment and Outcomes

In recent years, the mental health landscape has witnessed a growing demand for innovative and effective treatments. As rates of depression, anxiety, and other mental health disorders continue to climb, the need for novel treatments with less side effects becomes more urgent. 

Imagine a world where previously treatment-resistant mental health conditions can be addressed with newfound hope and success. This is the captivating promise of psychedelic-assisted therapy, a groundbreaking approach that combines age-old wisdom, cutting-edge science, and talk therapy. Join us as we embark on a journey to explore the fascinating interplay between psychedelic therapy, psychedelic drugs, and the treatment of mental disorders. 

Read along as we delve into the potential benefits and challenges of this emerging field of mental health. 

Psychedelic Assisted Therapy: A New Frontier in Mental Health

What is psychedelic assisted therapy

Psychedelic assisted therapy refers to a therapeutic approach that involves the use of psychedelic substances in a controlled and supportive setting to facilitate psychological healing and personal growth. This technique can be traced back to indigenous cultures that have harnessed psychedelic plants in healing rituals for centuries, most notably ayahuasca and psilocybin. 

In the mid-20th century, the advent of synthesized psychedelic substances, such as LSD, sparked a wave of research into their potential therapeutic applications. However, due to political and social factors, this research came to a halt in the 1970s.

The resurgence of psychedelics for mental health treatment

In recent years, there has been a renewed interest in the therapeutic potential of psychedelic substances. This revival is fueled by a combination of factors, including a growing body of scientific evidence, increased public awareness, and the recognition of the limitations of conventional treatments for mental health disorders. 

Several prestigious institutions, led by Johns Hopkins University and Imperial College London, have established dedicated research centers to study the efficacy and safety of psychedelic therapies and establish protocols in the treatment of different mental health disorders.

How does psychedelic assisted therapy work

Psychedelic assisted therapy offers a unique approach to mental health treatment, addressing the root causes of psychological distress rather than merely managing symptoms with medications that come with side effects. By inducing an altered state of consciousness supervised by a trained clinician, psychedelic substances can facilitate profound personal insights, emotional breakthroughs, and a greater sense of connection with oneself and others. 

This can lead to lasting improvements in mental health and well-being. However, it is essential to note that the success of psychedelic therapy is highly dependent on the set (the individual’s mindset) and setting (the therapeutic environment) in which the substances are administered.

Psychedelic Drugs: Key Players in Psychedelic-Assisted Therapy

Overview of the most common psychedelic drugs used in therapy

Psilocybin (magic mushrooms)

A naturally occurring compound found in certain species of mushrooms, psilocybin has been shown to effectively treat depression, anxiety, and addiction in clinical trials. Its effects include altered perceptions, increased introspection, and heightened emotional sensitivity.

Lysergic acid diethylamide (LSD)

A synthetic psychedelic substance, LSD has been researched for its potential in treating a variety of mental health disorders, including anxiety, depression, and PTSD. LSD can induce vivid visual and auditory hallucinations, profound shifts in perception, and increased self-awareness.

MDMA (molly, ecstasy)

Although not a classic psychedelic, MDMA is often included in the context of psychedelic therapy due to its ability to enhance empathy, self-compassion, and emotional openness. It has shown promise in the treatment of PTSD, social anxiety, and other trauma-related disorders.

Ayahuasca (DMT)

A traditional Amazonian plant-based brew, ayahuasca contains the powerful psychedelic compound DMT. It has been studied for its potential to treat addiction, depression, and anxiety. Ayahuasca can induce intense, visionary experiences and deep emotional processing.


Originally developed as an anesthetic, ketamine has emerged as a promising treatment for depression, particularly treatment-resistant depression. It is also used to address anxiety and PTSD. Ketamine can be administered via various routes, including intravenous infusion, intranasal spray, and oral ketamine lozenges. Its effects include dissociation, altered perceptions, and a profound sense of relaxation.

The science behind how psychedelics work in the brain

Psychedelic substances interact with various neurotransmitter systems in the brain, particularly the serotonin system. They often bind to the 5-HT2A serotonin receptor, which plays a crucial role in regulating mood, perception, and cognition. Ketamine, on the other hand, primarily acts on the glutamate system by blocking NMDA receptors. This receptor blockade leads to changes in neural activity and connectivity, allowing for enhanced introspection, emotional processing, and cognitive flexibility. 

These neurobiological effects, when combined with a supportive therapeutic environment, can facilitate lasting psychological change.

Safety and legal status of these substances

While psychedelic substances have a relatively low risk of addiction and are considered physiologically safe when used in controlled settings, they remain classified as illegal substances in many countries. 

However, there has been a shift in recent years, with some jurisdictions decriminalizing or legalizing the use of certain psychedelics for medical and therapeutic purposes. Ketamine, as a legally available medication, can be prescribed by physicians for off-label use in treating mental health disorders. It is essential to stay informed about the legal status of these substances and to only use them under the guidance of trained professionals in a therapeutic context.

Treatment of Mental Disorders with Psychedelic-Assisted Therapy

The role of psychedelic therapy in addressing mental health disorders


Psychedelic-assisted therapy, particularly with psilocybin, ketamine, and MDMA has demonstrated promising results in treating various forms of depression, including treatment-resistant depression. Patients often report reduced symptoms and improved mood following sessions, with some experiencing lasting relief after just a few guided sessions.


Research has shown that psychedelics, such as psilocybin and LSD, can significantly reduce anxiety levels in individuals with life-threatening illnesses, chronic anxiety disorders, and end-of-life. Patients typically experience a shift in perspective and greater emotional resilience after undergoing psychedelic-assisted therapy.

Post-traumatic stress disorder (PTSD)

MDMA-assisted therapy has emerged as a groundbreaking treatment option for individuals with PTSD. By fostering emotional openness and reducing fear, MDMA can help patients process and integrate traumatic memories, leading to significant symptom reduction and improved quality of life.

Obsessive-compulsive disorder (OCD)

Preliminary research suggests that psilocybin and other psychedelics may help alleviate symptoms of OCD by promoting cognitive flexibility and disrupting rigid thought patterns.


Psychedelic-assisted therapy, using substances like psilocybin, ketamine, and ayahuasca, has shown promise in treating various forms of addiction, such as alcohol, nicotine, and opioid dependencies. Patients often report increased self-awareness, a sense of spiritual connectedness, and a shift in priorities that can support lasting recovery.

Clinical trials and research evidence supporting the efficacy of psychedelic-assisted therapy

A growing body of research supports the efficacy of psychedelic-assisted therapy for various mental health disorders. Several randomized controlled trials and observational studies have demonstrated significant improvements in symptoms and overall well-being following psychedelic-assisted therapy. 

While the exact mechanisms underlying these benefits remain an area of ongoing investigation, it is clear that psychedelics, when used in a controlled and supportive environment, can catalyze profound psychological transformations.

A glimpse into a psychedelic-assisted therapy session

Psychedelic-assisted therapy typically involves a preparation stage, the psychedelic experience itself, and an integration phase. During the preparation stage, the therapist and patient build rapport, establish therapeutic goals, and discuss the patient’s intentions for the session. This stage helps create a foundation of trust and safety, setting the stage for a successful therapeutic experience.

On the day of the session, the patient is provided with a comfortable and calm setting, often with dim lighting, soft furnishings, and soothing music. The therapist administers the psychedelic substance, and the patient is encouraged to wear eye shades and focus on their inner experience as the drug takes effect. The therapist remains present throughout the session, providing support, guidance, and reassurance as needed.

During the psychedelic experience, patients may encounter a wide range of emotions, memories, and insights. The therapist helps the patient navigate these experiences, offering encouragement and validation as they process the material that arises. The duration of the session varies depending on the substance used, ranging from a few hours for ketamine to an entire day for substances like psilocybin or LSD.

Following the session, the integration phase begins. This involves discussing the insights and experiences from the psychedelic journey, identifying themes and patterns, and translating them into actionable steps for personal growth and healing. The integration process is essential for ensuring that the benefits of the psychedelic experience are fully realized and incorporated into the patient’s daily life.

The importance of a controlled and supervised environment during treatment

The success of psychedelic-assisted therapy is highly dependent on the set and setting in which the substances are administered. The set refers to the individual’s mindset, including their intentions, expectations, and emotional state. The setting encompasses the therapeutic environment, which should be comfortable, safe, and supportive. Trained professionals, such as therapists or psychiatrists, must be present to guide patients through the experience and help them process any challenging emotions or insights that may arise. This controlled and supervised approach ensures the safety and efficacy of psychedelic-assisted therapy, enabling patients to derive the maximum benefit from their experiences.

Psychedelic Assisted Therapy in Los Angeles

Psychedelic-assisted therapy, with its remarkable potential for treating mental health disorders, is truly revolutionizing the way we approach healing and well-being. At Psychedelica Collective in Los Angeles, we are proud to be part of this exciting movement, providing compassionate and evidence-based care that combines the transformative power of psychedelic substances and psychedelic assisted psychotherapy

Our dedicated team of professionals is devoted to guiding each patient on their unique journey toward self-discovery, growth, and lasting well-being. As we continue to explore and witness the extraordinary therapeutic potential of psychedelics, Psychedelica Collective stands as a leader in the field, helping to reshape the landscape of mental health care one life at a time.


Dive into the remarkable realm of LSD, a powerful psychedelic substance that has captivated the minds of inquisitive explorers for decades. Beyond its striking effects on consciousness, LSD presents a promising avenue for therapeutic and psychological advancements.

As researchers, mental health professionals, and psychonauts continue to unravel the enigma of LSD, its potential for fostering mental healing, reshaping our understanding of the human psyche, and transcending conventional realities becomes more evident. Embark on this enlightening journey as we uncover the intriguing world of LSD, its profound influences, and its promising role in shaping the future of mental health and personal growth.

What is LSD?

Lysergic acid diethylamide (LSD) is a synthetic psychoactive compound that belongs to the ergoline family of molecules. LSD earned prominence for its potent hallucinogenic and consciousness-altering properties.

As a serotonergic psychedelic, LSD primarily exerts its effects by interacting with the serotonin receptors in the brain, particularly the 5-HT2A receptor. This interaction leads to a cascade of neurochemical and physiological changes, resulting in the profound alterations in perception, cognition, and emotion commonly associated with the LSD experience.

Due to its unique properties, LSD has been the subject of extensive scientific investigation, with research increasingly focused on uncovering its potential therapeutic applications in the treatment of various mental health disorders.

portal to a another dimension assisted by the psychedelic dmt

History of LSD

The history of LSD is as captivating as the substance itself.

First synthesized in 1938 by Swiss chemist Albert Hofmann, LSD’s psychedelic effects were accidentally discovered by Hofmann in 1943 after he inadvertently ingested a small amount of the compound.

It was the 1960s, however, when LSD’s true impact on society began to unfold, as the substance played a crucial role in shaping the counterculture movement of the era. Key figures such as Aldous Huxley, Timothy Leary, and Alan Watts introduced LSD to the masses, leading to a widespread exploration of its effects on consciousness, spirituality, and personal growth.

This period also saw an outpouring of creativity and innovation, with LSD influencing various domains such as art, music, and literature.

In recent years, there has been a resurgence of interest in the therapeutic potential of psychedelics, including LSD, with a growing body of scientific research investigating its efficacy in treating mental health conditions such as anxiety, depression, and PTSD. Furthermore, the practice of microdosing—taking small, sub-perceptual doses of LSD—has gained popularity among professionals and creatives seeking to enhance their cognitive abilities, creativity, and overall well-being.

This renewed attention to LSD has sparked public discourse around the responsible use of psychedelics and their potential to transform lives, as well as a greater understanding of the substance’s complex and multifaceted role in our culture.

The Pharmacology of LSD

The pharmacology of LSD is complex and multifaceted, with the compound primarily interacting with the serotonin system in the brain. As a serotonergic psychedelic (like DMT and other classic hallucinogens), LSD binds to and activates several serotonin receptor subtypes, with the strongest affinity for the 5-HT2A receptor. This receptor activation is believed to be responsible for the majority of the characteristic psychedelic effects associated with LSD.

In addition to its interaction with the serotonin system, LSD also exhibits activity at dopamine and adrenergic receptors, which may contribute to its diverse range of effects on perception, cognition, and mood. The unique combination of receptor interactions allows LSD to produce an array of profound and often life-changing experiences, including altered perceptions, enhanced sensory experiences, and shifts in thought patterns and emotional states.

Despite its potent effects, LSD has a relatively low toxicity profile and is generally well-tolerated by the human body. It is important to note, however, that the powerful psychological effects of LSD can lead to challenging experiences for some individuals, emphasizing the need for appropriate set, setting, and preparation when using the substance.

Psychological benefits of LSD in Therapeutic Settings

The psychological benefits of LSD in therapeutic settings have been the subject of renewed interest in recent years, with a growing body of research suggesting its potential for treating various mental health conditions.

In controlled environments, LSD has shown promise for alleviating symptoms of anxiety, depression, and post-traumatic stress disorder (PTSD). By facilitating introspection, self-awareness, and emotional processing, LSD may help individuals confront and reframe maladaptive thought patterns and emotional responses.

Additionally, LSD-assisted psychotherapy has demonstrated potential for treating substance use disorders, particularly alcohol and nicotine dependence. The substance’s ability to promote lasting changes in perspective and self-understanding may help individuals identify the root causes of their addiction and make meaningful changes in their lives.

In end-of-life care, LSD has been found to reduce anxiety and existential distress in patients with terminal illnesses, allowing them to approach the end of life with greater peace and acceptance. These therapeutic effects are believed to be mediated by the profound mystical and spiritual experiences often reported during LSD-assisted therapy sessions, which can lead to lasting improvements in psychological well-being and overall quality of life.

While further research is needed to fully understand the potential applications and limitations of LSD in therapeutic settings, the initial findings suggest that it may represent a valuable tool for addressing various mental health challenges and promoting personal growth.

Revolutionizing Minds: LSD’s Therapeutic Renaissance and Pathways to Healing

Decades of research have begun to unveil the profound psychological benefits that LSD may offer in controlled therapeutic settings. Its potential for treating a range of mental health conditions, including anxiety, depression, substance use disorders, and existential distress, showcases the immense potential of this once-stigmatized compound. As the scientific community continues to explore the depths of LSD’s therapeutic applications, the future looks increasingly promising for those seeking relief from various mental health challenges.

While LSD remains a controlled substance in many jurisdictions, there are a few locations where legal, supervised psychedelic therapy is available. In countries like Switzerland and the Netherlands, for instance, certain organizations provide access to controlled, professionally guided experiences with psychedelic substances, including LSD. For those interested in exploring the therapeutic potential of LSD, it is essential to seek out reputable, regulated providers in order to ensure a safe and supportive environment for this transformative journey. As our understanding of LSD’s benefits continues to grow, we can hope for a future where access to this powerful healing tool becomes more widespread and recognized as a valuable component of mental health treatment.

Continue reading

DMT – N,N-dimethyltryptamine

Step into the enigmatic world of DMT, the “spirit molecule,” a naturally occurring compound that transports those who dare to explore it into a realm of unparalleled discovery. This powerful psychedelic, revered for its extraordinary effects on consciousness, is not only an incredible gateway to the unknown, but also holds the potential to be a clinically significant tool to overcome mental illness.

As scientists and spiritual seekers alike delve deeper into the mysteries of DMT, its potential for healing the mind, unraveling the secrets of our existence, and transcending the boundaries of our reality becomes increasingly apparent. Join us on this fascinating journey to uncover the captivating world of DMT, its transformative effects, and its potential role in the future of mental health and personal growth.

What is DMT?

Dimethyltryptamine, or DMT, is a naturally occurring psychedelic alkaloid found in several species of plants such as Psychotria viridis, Mimosa tenuiflora, or Acacia confusa. Additionally, close variants of DMT can also be the Colorado River toad, and in trace amounts in certain mammalian tissues. 

DMT is nicknamed the “spirit molecule” due to its intense and mystical effects. This compound belongs to the tryptamine class of molecules, which also includes other well-known psychedelics such as psilocybin and LSD.

When consumed, either through ingestion or inhalation, DMT rapidly transports users into an immersive, kaleidoscopic world of vivid geometric patterns, intricate fractals, and otherworldly landscapes. Often accompanied by encounters with sentient beings or entities, a DMT experience can evoke profound spiritual and emotional revelations.

Although DMT is a potent and fast-acting hallucinogen, its effects are typically short-lived, with most experiences lasting between 15 to 45 minutes. As researchers continue to study this fascinating compound, its potential applications in mental health and personal growth continue to generate interest and spark discussion.

portal to a another dimension assisted by the psychedelic dmt

History of DMT

The history of DMT is a fascinating journey that stretches across cultures and time. While the exact origins of DMT use remain uncertain, its presence in various plants has long been recognized by indigenous cultures, particularly in South America. Traditional Amazonian tribes have utilized DMT containing plants to prepare the sacred brew ayahuasca for spiritual and healing purposes.

DMT’s presence in the modern world can be dated back to 1931 when British chemist Richard Manske first synthesized the compound. However, it wasn’t until the 1950s that its psychoactive properties were discovered by Hungarian chemist Stephen Szára. Shortly thereafter DMT gained traction in the psychedelic research community, and its effects on human consciousness were further explored.

In the 1990s, the enigmatic nature of DMT caught the attention of Dr. Rick Strassman, who conducted extensive research on the compound. He administered DMT to human volunteers in a controlled setting, leading to groundbreaking insights into its effects on the human mind. Strassman’s research, published in his book “DMT: The Spirit Molecule,” brought DMT into the mainstream, sparking widespread interest in the compound’s therapeutic potential and spiritual implications.

The Pharmacology of DMT

DMT interacts with a type of serotonin receptor in our central nervous system, known as the 5-HT2A receptor. This interaction alters brain activity and releases various neurotransmitters, including serotonin which inhibits dopamine and adrenaline leading to the intense and mystical experiences associated with DMT.

Users often report vivid visual and auditory hallucinations, profound mystical experiences, and encounters with seemingly sentient beings.
There is some evidence that suggests that naturally occurring DMT within our bodies might be involved in dreaming, near-death experiences, and altered states of consciousness, but more studies are needed to confirm these ideas.

As interest in the therapeutic potential of psychedelics continues to grow, understanding DMT’s inner workings and effects is crucial for exploring its possible applications in mental health and personal growth.

Psychological benefits of DMT

Over the past decade, DMT has generated a surge of excitement in the field of mental health, as researchers probe its potential to revolutionize the treatment of treatment resistant mental illnesses. With its unique ability to trigger intense, transformative experiences, DMT is capturing the attention of scientists who are eager to uncover its potential benefits for individuals struggling with depression, anxiety, PTSD, and addiction.

There is growing hope that this enigmatic compound may hold the key to unlocking new, innovative approaches to treating mental health disorders that have long been resistant to traditional therapies. As our understanding of DMT’s potential unfolds, the prospects for a brighter future in mental health care become increasingly tangible, inspiring both researchers and patients to explore the vast potential that lies within this extraordinary molecule.

Embracing the Future: DMT’s Therapeutic Promise and the Path to Treatment

With ongoing research and promising results, there is a growing sense of optimism for DMT’s future as a therapeutic agent in mental health treatment. As we continue to uncover its potential benefits for a range of mental health conditions, from depression and anxiety to PTSD and addiction, the prospects for innovative and transformative therapies become increasingly tangible.

While the use of DMT in clinical settings is still limited due to legal restrictions and the need for more research, interest in its therapeutic potential continues to soar. For those seeking DMT treatment or experiences, it is essential to consider the legal status and safety implications in your region. In some countries and contexts, legally sanctioned retreat centers and ceremonies led by experienced practitioners offer a safe and supportive environment for exploring the healing potential of DMT and related substances, such as ayahuasca.

As our understanding of DMT evolves, we can look forward to a future where its remarkable potential is harnessed for the betterment of mental health and personal growth.

Continue reading


Embark on a journey into the mystical heart of the Amazon rainforest, where a sacred, ancient elixir has captivated the minds and spirits of generations. Ayahuasca, a potent South American concoction, boasts a rich tapestry of history and cultural significance. Used ceremonially to unlock the doors of perception, this enigmatic brew entwines the potential for profound healing with a kaleidoscope of powerful psychoactive effects.

What is Ayahuasca?

Ayahuasca – also known as hoasca, caapi, or yagé –  is a sacred brew that originates from indigenous cultures in the Amazon rainforest who have used it for centuries in healing rituals and spiritual ceremonies. These ceremonies are led by a healer, or shaman, who prepares the the medicine and oversees the journey of. those who are participating in the ritual.

Traditionally, this brew is made by combining two primary ingredients: the Banisteriopsis caapi vine and the Psychotria viridis leaf, and boiling them into a concentrated tonic which together create a powerfulhallucinogenic effect.

Personal Journey Through the Jungle: Ayahuasca Experience

What Ayahuasca Does to the Brain

In the depths of the Amazon rainforest, a synergistic dance between two powerful compounds gives rise to the extraordinary psychoactive effects of ayahuasca.

The first component, N,N-dimethyltryptamine (DMT), derived from the Psychotria viridis plant, is a potent hallucinogen that can induce vivid visions and alter one’s perception of reality.

However, on its own, DMT is rapidly broken down in the digestive system by monoamine oxidase (MAO) enzymes, rendering it inactive when taken orally.

This is where the second key player, monoamine oxidase inhibitors (MAOIs), found in the Banisteriopsis caapi vine, step in. MAOIs block the action of the MAO enzymes, allowing DMT to bypass degradation and enter the bloodstream.

This intricate interplay between DMT and MAOIs in the ayahuasca brew creates a potent, orally-active concoction that unlocks the door to a profound and transformative psychoactive experience.

Embracing Ancient Wisdom: Ayahuasca Ceremonies in the Modern World

The ceremonial use of ayahuasca dates back centuries, deeply rooted in the indigenous cultures of the Amazon rainforest.

In these traditional settings, ayahuasca is regarded as a powerful spiritual medicine that connects participants with a higher state of consciousness, guided by the wisdom of ancestral spirits. Led by shamans or traditional healers, ayahuasca ceremonies often take place at night, featuring elements such as sacred songs called “icaros,” rhythmic drumming, and prayer, which help guide participants through their spiritual journeys.

In recent years, the allure of these ancient rituals has permeated modern culture, drawing an increasing number of spiritual seekers and those looking for alternative forms of healing to embark on ayahuasca retreats in South America or attend ceremonies held in various parts of the world. This growing interest has sparked a broader conversation about the value of traditional wisdom and the potential for bridging the gap between ancient practices and modern therapeutic approaches, ultimately contributing to a renewed appreciation for the rich cultural heritage surrounding ayahuasca and its potential role in holistic well-being.

Psychological benefits of ayahuasca

Ayahuasca has garnered significant attention for its potential psychological benefits, as countless individuals have reported profound healing and personal growth following their experiences with the sacred brew.

Ayahuasca benefits on mental health

Emerging research suggests that ayahuasca may have therapeutic potential in alleviating symptoms of depression, anxiety, and PTSD by promoting introspection and self-awareness.

A study published in 2018 in the Journal of Psychopharmacology found that ayahuasca could significantly reduce symptoms of treatment-resistant depression in a small group of participants.

Furthermore, a 2014 book chapter by Nielson and Megler explored the use of ayahuasca as a candidate therapy for PTSD, highlighting its potential role in alleviating trauma-related symptoms. It is believed that the unique psychoactive properties of ayahuasca facilitate a deep, introspective journey, allowing individuals to confront their emotions, past traumas, and core beliefs, fostering psychological resilience and growth

Ayahuasca in addiction treatment

Additionally, ayahuasca has been utilized in the realm of addiction recovery, as the insights gained during the experience can help users understand the root causes of their substance abuse and encourage them to make lasting positive changes.

In fact, a 2018 study showed that ayahuasca could reduce the severity of alcohol, tobacco, and cocaine dependence, highlighting its potential in the realm of addiction recovery.

While the use of ayahuasca in clinical therapeutic settings remains limited due to legal restrictions and the need for further research, its potential as a powerful tool for psychological healing continues to intrigue both scientists and spiritual seekers alike.

Ayahuasca’s Promising Horizon: A New Dawn for Mental Health and Healing

In conclusion, ayahuasca’s rich cultural history, profound spiritual significance, and promising therapeutic potential make it an intriguing subject for both spiritual seekers and mental health professionals.

As research continues to explore the psychological benefits of this ancient Amazonian brew, there is growing optimism that ayahuasca may play an increasingly important role in the future of mental health treatment.

For those interested in experiencing the potential healing properties of ayahuasca, carefully curated retreats and ceremonies led by experienced practitioners can be found in countries where its use is legal, such as Peru, Brazil, and Costa Rica. However, it is essential to thoroughly research and choose a reputable, safe, and supportive environment to minimize risks and ensure the best possible outcome.

As our understanding of ayahuasca’s therapeutic properties deepens, we may be witnessing the dawn of a new era in holistic well-being, where ancient wisdom and modern science join forces to address some of humanity’s most pressing mental health challenges.

Continue reading

MDMA – 3,4-methylenedioxy-methylamphetamine

Over the past few years, MDMA, the psychoactive substance also commonly known as “ecstasy” or “molly,” has gained attention as a potential therapeutic tool for treating mental health conditions such as PTSD, anxiety, and depression. Despite its reputation as a “club drug”, emerging data from clinical trials have shown MDMA-assisted psychotherapy is a promising treatment for individuals struggling with mental illness.

MDMA: A Brief History

3,4-methylenedioxy-methylamphetamine, or MDMA, is a synthetic pharmaceutical synthesized by German pharmaceutical giant Merck in the early 20th century. Its intended use when patented was to serve as a clotting agent to control bleeding, It was not until decades later that this medication began getting attention from psychiatrists after initial studies began reporting on its physiological effects.

Thus began a small wave of unofficial research being conducted by psychiatrists and psychotherapists whose clients were communicating more effectively and making deeper insights about their issues.

Around this time illicit MDMA was becoming more accessible on the street and quickly seeped into underground rave subculture in the 80’s and soon thereafter became classified as a Schedule I Drug by the DEA.

It wasn’t until early the 2000’s that research MDMA’s therapeutic benefit for mental health resumed and has since shown tremendous promise as an adjunct treatment to psychotherapy, especially for PTSD, anxiety, and mood disorders.

mdma is being investigated as an effective anxiolytic or antidepressant to be

How Does MDMA Affect the Brain

MDMA is a empathogen-entactogen that alters brain chemistry by affecting the levels of several neurotransmitters, including serotonin, dopamine, and norepinephrine. Chemically, MDMA is a phenethylamine derivative with a substituted amphetamine group. It shares some chemical structures with mescaline, a serotonergic psychedelic, from which it may draw its psychoactive properties from.

When ingested, MDMA is rapidly absorbed into the bloodstream, crosses the blood-brain barrier, and enters the brain, where it acts as a serotonin agonist, increasing its release and blocking its reuptake. This results in a surge of positive emotions, feelings of empathy and social connectedness, and an altered sense of time perception.

Additionally, MDMA affects the release of dopamine and norepinephrine, which can contribute to its stimulant-like effects. However, prolonged or repeated use of MDMA can lead to long-term changes in the brain’s serotonin system, which may contribute to the development of tolerance, dependence, and other adverse effects.

Legality of MDMA in Therapeutic Settings

In recent years, the legal landscape around therapeutic MDMA and MDMA-assisted psychotherapy has been changing. The US Food and Drug Administration (FDA) granted MDMA-assisted psychotherapy a “Breakthrough Therapy” designation in 2017, indicating that it may offer significant benefits over existing treatments for certain conditions. This designation allows for expedited development and review of the treatment.

In 2021, the FDA granted “Expanded Access” status to a limited number of patients with PTSD, allowing them to receive MDMA-assisted psychotherapy while the medication is still undergoing clinical trials. This decision reflects a growing recognition of the potential therapeutic benefits of MDMA for mental health conditions.

Additionally, in some places, such as Canada, the use of MDMA in clinical trials for certain conditions is legal, and some countries have decriminalized personal use of MDMA. However, the use of MDMA for any purpose outside of approved clinical trials remains illegal in most countries.

Continue reading

Ketamine: the Legal Psychedelic That’s Changing Mental Health Treatment

A medication used for decades in medical settings as an sedative and dissociative agent, ketamine is experiencing a rebirth as a revolutionary treatment for depression and other hard to treat mental illnesses. Despite its notorious reputation as a party drug and hallucinogen, ketamine possesses powerful therapeutic potential when used in controlled settings.

Despite having a distinct chemical composition compared to other hallucinogens (e.g. psilocybin, DMT, LSD), therapeutic benefit remains is similar.

From Anesthetic to Promising Antidepressant

First synthesized in 1962 by chemist Calvin Stevens, ketamine was initially developed as an alternative to phencyclidine (PCP). At the time, PCP which was a commonly used anesthetic but came with severe psychological side effects. Ketamine was introduced for human use in 1970 and quickly became a popular anesthetic in surgical and battlefield settings due to its rapid onset and short duration of action.

Due to it’s dissociative effects, ketamine hit the club scene as a recreational drug in the 1990s. In recent years, evidence of it’s benefits for treating a variety of mental health disorders has emerged making it the newest off-label therapy for depression and anxiety.

How Does Ketamine Impact the Brain

Ketamine works by blocking N-methyl-D-aspartate (NMDA) receptors in the brain, which are involved in pain perception, learning, and memory. This is what  produces a dissociative, euphoric, and anesthetic effect. It is also thought to increase the release of neurotransmitters such as dopamine and serotonin, which are associated with mood regulation hence its proposed use in the treatment of mental illness.

Ketamine can be administered intravenously, intramuscularly, and nasally (see Spravato), all forms with a rapid onset of action and whose effects are typically felt within minutes lasting between 30 minutes to an hour depending on the dose.

What are the Benefits of Ketamine?

Ketamine has been used as an anesthetic in medical settings for decades. It is also increasingly being used to treat a range of conditions, including chronic pain, depression, anxiety, and post-traumatic stress disorder (PTSD). In low doses, ketamine has been shown to have rapid antidepressant effects, making it a promising treatment for treatment-resistant depression.

Ketamine is also being studied for its potential use in the treatment of other psychiatric disorders, such as bipolar disorder and obsessive-compulsive disorder (OCD). However, more research is needed to determine its effectiveness and safety for these conditions.

Continue reading

  • 1
  • 2